nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—L-Phenylalanine—Nateglinide—type 2 diabetes mellitus	0.455	1	CrCrCtD
Melphalan—SLC22A3—Metformin—type 2 diabetes mellitus	0.135	1	CbGbCtD
Melphalan—SLC22A3—Abacavir transport and metabolism—PCK1—type 2 diabetes mellitus	0.00532	0.0732	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.00376	0.0517	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—GRB14—type 2 diabetes mellitus	0.00291	0.04	CbGpPWpGaD
Melphalan—SLC7A5—islet of Langerhans—type 2 diabetes mellitus	0.00265	0.143	CbGeAlD
Melphalan—Ibuprofen—THBD—type 2 diabetes mellitus	0.0026	0.405	CrCbGaD
Melphalan—SLC7A5—retina—type 2 diabetes mellitus	0.00226	0.123	CbGeAlD
Melphalan—SLC7A5—nephron tubule—type 2 diabetes mellitus	0.00213	0.115	CbGeAlD
Melphalan—SLC7A5—cardiovascular system—type 2 diabetes mellitus	0.00191	0.104	CbGeAlD
Melphalan—SLC7A5—Basigin interactions—MMP1—type 2 diabetes mellitus	0.00191	0.0262	CbGpPWpGaD
Melphalan—SLC7A5—pancreas—type 2 diabetes mellitus	0.00186	0.101	CbGeAlD
Melphalan—SLC7A5—cortex of kidney—type 2 diabetes mellitus	0.00182	0.0988	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CYP1A2—type 2 diabetes mellitus	0.0018	0.0247	CbGpPWpGaD
Melphalan—Ibuprofen—PLAT—type 2 diabetes mellitus	0.00178	0.277	CrCbGaD
Melphalan—SLC7A5—adipose tissue—type 2 diabetes mellitus	0.00169	0.0915	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00168	0.0231	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—THBD—type 2 diabetes mellitus	0.00142	0.0195	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00126	0.0173	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.00121	0.0166	CbGpPWpGaD
Melphalan—SLC7A5—liver—type 2 diabetes mellitus	0.00118	0.0641	CbGeAlD
Melphalan—SLC22A3—kidney—type 2 diabetes mellitus	0.00116	0.063	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.00112	0.0154	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.00108	0.0149	CbGpPWpGaD
Melphalan—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.00105	0.0568	CbGeAlD
Melphalan—Ibuprofen—BCL2—type 2 diabetes mellitus	0.00102	0.159	CrCbGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000988	0.0136	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000951	0.0131	CbGpPWpGaD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SNAP25—type 2 diabetes mellitus	0.000931	0.0128	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000882	0.0121	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000855	0.0118	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000853	0.0117	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000849	0.0117	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—GRB14—type 2 diabetes mellitus	0.000788	0.0108	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—APOB—type 2 diabetes mellitus	0.000766	0.0105	CbGpPWpGaD
Melphalan—SLC22A3—liver—type 2 diabetes mellitus	0.000734	0.0398	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000722	0.00992	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000697	0.00959	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.00065	0.00894	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MMP1—type 2 diabetes mellitus	0.000634	0.00872	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	0.000627	0.00863	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.00058	0.00798	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.00057	0.00785	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000569	0.00783	CbGpPWpGaD
Melphalan—Ibuprofen—PPARG—type 2 diabetes mellitus	0.000567	0.0883	CrCbGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	0.000561	0.00771	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000554	0.00761	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000551	0.00758	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	0.00055	0.00756	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00055	0.00756	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00055	0.00756	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.00054	0.00743	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	0.000524	0.0072	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000503	0.00691	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000483	0.00664	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3R1—type 2 diabetes mellitus	0.000459	0.00632	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ATP2A3—type 2 diabetes mellitus	0.000452	0.00622	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000449	0.00618	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000449	0.00618	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000448	0.00616	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000448	0.00616	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000434	0.00598	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000432	0.00595	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000431	0.00593	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000431	0.00593	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000431	0.00592	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000424	0.00583	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000392	0.00539	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—THBD—type 2 diabetes mellitus	0.000385	0.00529	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000368	0.00506	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000367	0.00504	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000366	0.00504	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000355	0.00488	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000354	0.00487	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SRC—type 2 diabetes mellitus	0.00034	0.00467	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.00034	0.00467	CbGpPWpGaD
Melphalan—Flushing—Irbesartan—type 2 diabetes mellitus	0.000326	0.00104	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ATP2A2—type 2 diabetes mellitus	0.000325	0.00447	CbGpPWpGaD
Melphalan—Pruritus—Glipizide—type 2 diabetes mellitus	0.000324	0.00104	CcSEcCtD
Melphalan—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000323	0.00103	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000321	0.00103	CcSEcCtD
Melphalan—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000318	0.00102	CcSEcCtD
Melphalan—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000317	0.00101	CcSEcCtD
Melphalan—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000316	0.00101	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—TRPC6—type 2 diabetes mellitus	0.000315	0.00434	CbGpPWpGaD
Melphalan—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000315	0.00101	CcSEcCtD
Melphalan—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000315	0.00101	CcSEcCtD
Melphalan—Infection—Gliclazide—type 2 diabetes mellitus	0.000314	0.001	CcSEcCtD
Melphalan—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000314	0.001	CcSEcCtD
Melphalan—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000314	0.001	CcSEcCtD
Melphalan—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000314	0.001	CcSEcCtD
Melphalan—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000313	0.001	CcSEcCtD
Melphalan—Cough—Valsartan—type 2 diabetes mellitus	0.000311	0.000993	CcSEcCtD
Melphalan—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000311	0.000993	CcSEcCtD
Melphalan—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00031	0.000991	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—F7—type 2 diabetes mellitus	0.00031	0.00426	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.00031	0.00099	CcSEcCtD
Melphalan—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00031	0.00099	CcSEcCtD
Melphalan—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000309	0.000987	CcSEcCtD
Melphalan—Jaundice—Ramipril—type 2 diabetes mellitus	0.000308	0.000985	CcSEcCtD
Melphalan—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000308	0.000985	CcSEcCtD
Melphalan—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000307	0.000982	CcSEcCtD
Melphalan—Cough—Orlistat—type 2 diabetes mellitus	0.000307	0.000982	CcSEcCtD
Melphalan—Flushing—Losartan—type 2 diabetes mellitus	0.000307	0.000982	CcSEcCtD
Melphalan—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000307	0.00098	CcSEcCtD
Melphalan—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000306	0.000979	CcSEcCtD
Melphalan—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000306	0.000979	CcSEcCtD
Melphalan—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000306	0.000977	CcSEcCtD
Melphalan—Convulsion—Orlistat—type 2 diabetes mellitus	0.000305	0.000975	CcSEcCtD
Melphalan—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000304	0.000972	CcSEcCtD
Melphalan—Chest pain—Valsartan—type 2 diabetes mellitus	0.000303	0.000969	CcSEcCtD
Melphalan—Myalgia—Valsartan—type 2 diabetes mellitus	0.000303	0.000969	CcSEcCtD
Melphalan—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000302	0.000966	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000301	0.000963	CcSEcCtD
Melphalan—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.0003	0.000959	CcSEcCtD
Melphalan—Chest pain—Orlistat—type 2 diabetes mellitus	0.0003	0.000958	CcSEcCtD
Melphalan—Myalgia—Orlistat—type 2 diabetes mellitus	0.0003	0.000958	CcSEcCtD
Melphalan—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000299	0.000956	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000298	0.000951	CcSEcCtD
Melphalan—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000296	0.000945	CcSEcCtD
Melphalan—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000296	0.000945	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000295	0.00406	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000295	0.00405	CbGpPWpGaD
Melphalan—Alopecia—Losartan—type 2 diabetes mellitus	0.000292	0.000935	CcSEcCtD
Melphalan—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000292	0.000934	CcSEcCtD
Melphalan—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000291	0.000931	CcSEcCtD
Melphalan—Vomiting—Glipizide—type 2 diabetes mellitus	0.000291	0.00093	CcSEcCtD
Melphalan—Oedema—Valsartan—type 2 diabetes mellitus	0.000291	0.000929	CcSEcCtD
Melphalan—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000291	0.000929	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.00029	0.00399	CbGpPWpGaD
Melphalan—Infection—Valsartan—type 2 diabetes mellitus	0.000289	0.000923	CcSEcCtD
Melphalan—Rash—Glipizide—type 2 diabetes mellitus	0.000289	0.000923	CcSEcCtD
Melphalan—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000288	0.000922	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000288	0.000921	CcSEcCtD
Melphalan—Oedema—Orlistat—type 2 diabetes mellitus	0.000287	0.000918	CcSEcCtD
Melphalan—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000287	0.000918	CcSEcCtD
Melphalan—Infection—Orlistat—type 2 diabetes mellitus	0.000285	0.000912	CcSEcCtD
Melphalan—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000285	0.00091	CcSEcCtD
Melphalan—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000284	0.000908	CcSEcCtD
Melphalan—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000284	0.000907	CcSEcCtD
Melphalan—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000283	0.000904	CcSEcCtD
Melphalan—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000282	0.000903	CcSEcCtD
Melphalan—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000282	0.000902	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000282	0.00388	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000281	0.00387	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000281	0.00387	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00028	0.00385	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00028	0.00385	CbGpPWpGaD
Melphalan—Urticaria—Glyburide—type 2 diabetes mellitus	0.00028	0.000895	CcSEcCtD
Melphalan—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000279	0.000892	CcSEcCtD
Melphalan—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000279	0.000891	CcSEcCtD
Melphalan—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000278	0.00089	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ADRA2A—type 2 diabetes mellitus	0.000278	0.00382	CbGpPWpGaD
Melphalan—Anorexia—Valsartan—type 2 diabetes mellitus	0.000277	0.000886	CcSEcCtD
Melphalan—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000277	0.000884	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—TIMP1—type 2 diabetes mellitus	0.000276	0.0038	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLAT—type 2 diabetes mellitus	0.000276	0.0038	CbGpPWpGaD
Melphalan—Myalgia—Metformin—type 2 diabetes mellitus	0.000276	0.000883	CcSEcCtD
Melphalan—Chest pain—Metformin—type 2 diabetes mellitus	0.000276	0.000883	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000275	0.00379	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000275	0.00378	CbGpPWpGaD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000274	0.000877	CcSEcCtD
Melphalan—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000274	0.000876	CcSEcCtD
Melphalan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000273	0.000873	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000273	0.00375	CbGpPWpGaD
Melphalan—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000273	0.000872	CcSEcCtD
Melphalan—Nausea—Glipizide—type 2 diabetes mellitus	0.000272	0.000869	CcSEcCtD
Melphalan—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000272	0.000868	CcSEcCtD
Melphalan—Hypotension—Valsartan—type 2 diabetes mellitus	0.000272	0.000868	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000271	0.00373	CbGpPWpGaD
Melphalan—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000271	0.000866	CcSEcCtD
Melphalan—Pain—Gliclazide—type 2 diabetes mellitus	0.000271	0.000865	CcSEcCtD
Melphalan—Rash—Glimepiride—type 2 diabetes mellitus	0.000269	0.000861	CcSEcCtD
Melphalan—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000269	0.00086	CcSEcCtD
Melphalan—Rash—Sitagliptin—type 2 diabetes mellitus	0.000269	0.000858	CcSEcCtD
Melphalan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000268	0.000858	CcSEcCtD
Melphalan—Cough—Irbesartan—type 2 diabetes mellitus	0.000267	0.000854	CcSEcCtD
Melphalan—Anaemia—Losartan—type 2 diabetes mellitus	0.000266	0.000851	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000265	0.000847	CcSEcCtD
Melphalan—Oedema—Metformin—type 2 diabetes mellitus	0.000265	0.000846	CcSEcCtD
Melphalan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000264	0.000843	CcSEcCtD
Melphalan—Flushing—Ramipril—type 2 diabetes mellitus	0.000263	0.000842	CcSEcCtD
Melphalan—Infection—Metformin—type 2 diabetes mellitus	0.000263	0.000841	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000262	0.000836	CcSEcCtD
Melphalan—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000261	0.000834	CcSEcCtD
Melphalan—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000261	0.000833	CcSEcCtD
Melphalan—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000261	0.000833	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—NOS1—type 2 diabetes mellitus	0.00026	0.00357	CbGpPWpGaD
Melphalan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00026	0.00083	CcSEcCtD
Melphalan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000259	0.000828	CcSEcCtD
Melphalan—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000259	0.000828	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000259	0.000827	CcSEcCtD
Melphalan—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000258	0.000824	CcSEcCtD
Melphalan—Leukopenia—Losartan—type 2 diabetes mellitus	0.000258	0.000824	CcSEcCtD
Melphalan—Skin disorder—Metformin—type 2 diabetes mellitus	0.000257	0.000822	CcSEcCtD
Melphalan—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000256	0.000819	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000256	0.00352	CbGpPWpGaD
Melphalan—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000256	0.000818	CcSEcCtD
Melphalan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000256	0.000817	CcSEcCtD
Melphalan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000254	0.000811	CcSEcCtD
Melphalan—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000253	0.00081	CcSEcCtD
Melphalan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000253	0.000809	CcSEcCtD
Melphalan—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000253	0.000808	CcSEcCtD
Melphalan—Asthenia—Glyburide—type 2 diabetes mellitus	0.000253	0.000808	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PTPN1—type 2 diabetes mellitus	0.000253	0.00348	CbGpPWpGaD
Melphalan—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000253	0.000808	CcSEcCtD
Melphalan—Anorexia—Metformin—type 2 diabetes mellitus	0.000252	0.000807	CcSEcCtD
Melphalan—Cough—Losartan—type 2 diabetes mellitus	0.000251	0.000803	CcSEcCtD
Melphalan—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000251	0.000803	CcSEcCtD
Melphalan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000251	0.000802	CcSEcCtD
Melphalan—Alopecia—Ramipril—type 2 diabetes mellitus	0.000251	0.000801	CcSEcCtD
Melphalan—Fatigue—Valsartan—type 2 diabetes mellitus	0.000251	0.000801	CcSEcCtD
Melphalan—Oedema—Irbesartan—type 2 diabetes mellitus	0.00025	0.000799	CcSEcCtD
Melphalan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00025	0.000799	CcSEcCtD
Melphalan—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00025	0.000798	CcSEcCtD
Melphalan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000249	0.000797	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—RASGRP1—type 2 diabetes mellitus	0.000249	0.00342	CbGpPWpGaD
Melphalan—Infection—Irbesartan—type 2 diabetes mellitus	0.000248	0.000793	CcSEcCtD
Melphalan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000248	0.000793	CcSEcCtD
Melphalan—Fatigue—Orlistat—type 2 diabetes mellitus	0.000248	0.000792	CcSEcCtD
Melphalan—Hypotension—Metformin—type 2 diabetes mellitus	0.000247	0.000791	CcSEcCtD
Melphalan—Pain—Orlistat—type 2 diabetes mellitus	0.000246	0.000785	CcSEcCtD
Melphalan—Myalgia—Losartan—type 2 diabetes mellitus	0.000245	0.000784	CcSEcCtD
Melphalan—Chest pain—Losartan—type 2 diabetes mellitus	0.000245	0.000784	CcSEcCtD
Melphalan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000245	0.000783	CcSEcCtD
Melphalan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000245	0.000782	CcSEcCtD
Melphalan—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000244	0.000779	CcSEcCtD
Melphalan—Rash—Bromocriptine—type 2 diabetes mellitus	0.000243	0.000777	CcSEcCtD
Melphalan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000243	0.000776	CcSEcCtD
Melphalan—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000243	0.000776	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000241	0.000771	CcSEcCtD
Melphalan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000241	0.000771	CcSEcCtD
Melphalan—Ibuprofen—PTGS2—type 2 diabetes mellitus	0.000239	0.0373	CrCbGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000239	0.00329	CbGpPWpGaD
Melphalan—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000238	0.000761	CcSEcCtD
Melphalan—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000238	0.00076	CcSEcCtD
Melphalan—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000236	0.000754	CcSEcCtD
Melphalan—Oedema—Losartan—type 2 diabetes mellitus	0.000235	0.000751	CcSEcCtD
Melphalan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000235	0.000751	CcSEcCtD
Melphalan—Infection—Losartan—type 2 diabetes mellitus	0.000234	0.000747	CcSEcCtD
Melphalan—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000233	0.000746	CcSEcCtD
Melphalan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000233	0.000745	CcSEcCtD
Melphalan—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000233	0.000745	CcSEcCtD
Melphalan—Urticaria—Valsartan—type 2 diabetes mellitus	0.000231	0.000738	CcSEcCtD
Melphalan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00023	0.000736	CcSEcCtD
Melphalan—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00023	0.000736	CcSEcCtD
Melphalan—Tachycardia—Losartan—type 2 diabetes mellitus	0.000229	0.000733	CcSEcCtD
Melphalan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000229	0.000732	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000229	0.00315	CbGpPWpGaD
Melphalan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000229	0.000731	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000228	0.00314	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000228	0.00314	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000228	0.00314	CbGpPWpGaD
Melphalan—Fatigue—Metformin—type 2 diabetes mellitus	0.000228	0.00073	CcSEcCtD
Melphalan—Urticaria—Orlistat—type 2 diabetes mellitus	0.000228	0.000729	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000228	0.000728	CcSEcCtD
Melphalan—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000227	0.000726	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SOD1—type 2 diabetes mellitus	0.000225	0.0031	CbGpPWpGaD
Melphalan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000224	0.000717	CcSEcCtD
Melphalan—Anorexia—Losartan—type 2 diabetes mellitus	0.000224	0.000716	CcSEcCtD
Melphalan—Vomiting—Glyburide—type 2 diabetes mellitus	0.000224	0.000716	CcSEcCtD
Melphalan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000224	0.000716	CcSEcCtD
Melphalan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000223	0.000712	CcSEcCtD
Melphalan—Rash—Glyburide—type 2 diabetes mellitus	0.000222	0.00071	CcSEcCtD
Melphalan—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000222	0.000709	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000222	0.00305	CbGpPWpGaD
Melphalan—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000221	0.000707	CcSEcCtD
Melphalan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00022	0.000703	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.00022	0.00302	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.00022	0.00302	CbGpPWpGaD
Melphalan—Hypotension—Losartan—type 2 diabetes mellitus	0.00022	0.000702	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000219	0.00302	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000219	0.00301	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—GNB3—type 2 diabetes mellitus	0.000218	0.003	CbGpPWpGaD
Melphalan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000217	0.000694	CcSEcCtD
Melphalan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000216	0.000692	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000216	0.00297	CbGpPWpGaD
Melphalan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000216	0.000689	CcSEcCtD
Melphalan—Cough—Ramipril—type 2 diabetes mellitus	0.000216	0.000689	CcSEcCtD
Melphalan—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000215	0.000688	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000214	0.000685	CcSEcCtD
Melphalan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000214	0.000685	CcSEcCtD
Melphalan—Convulsion—Ramipril—type 2 diabetes mellitus	0.000214	0.000684	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IGF2—type 2 diabetes mellitus	0.000214	0.00294	CbGpPWpGaD
Melphalan—Pain—Irbesartan—type 2 diabetes mellitus	0.000214	0.000683	CcSEcCtD
Melphalan—Ibuprofen—ALB—type 2 diabetes mellitus	0.000213	0.0332	CrCbGaD
Melphalan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000212	0.000676	CcSEcCtD
Melphalan—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000211	0.000675	CcSEcCtD
Melphalan—Urticaria—Metformin—type 2 diabetes mellitus	0.00021	0.000672	CcSEcCtD
Melphalan—Myalgia—Ramipril—type 2 diabetes mellitus	0.00021	0.000672	CcSEcCtD
Melphalan—Chest pain—Ramipril—type 2 diabetes mellitus	0.00021	0.000672	CcSEcCtD
Melphalan—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00021	0.00067	CcSEcCtD
Melphalan—Nausea—Glyburide—type 2 diabetes mellitus	0.000209	0.000669	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000209	0.000668	CcSEcCtD
Melphalan—Asthenia—Valsartan—type 2 diabetes mellitus	0.000209	0.000667	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—APOB—type 2 diabetes mellitus	0.000208	0.00286	CbGpPWpGaD
Melphalan—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000207	0.000661	CcSEcCtD
Melphalan—Asthenia—Orlistat—type 2 diabetes mellitus	0.000206	0.000659	CcSEcCtD
Melphalan—Pruritus—Valsartan—type 2 diabetes mellitus	0.000206	0.000657	CcSEcCtD
Melphalan—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000204	0.000653	CcSEcCtD
Melphalan—Pruritus—Orlistat—type 2 diabetes mellitus	0.000203	0.00065	CcSEcCtD
Melphalan—Fatigue—Losartan—type 2 diabetes mellitus	0.000203	0.000648	CcSEcCtD
Melphalan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000202	0.000644	CcSEcCtD
Melphalan—Oedema—Ramipril—type 2 diabetes mellitus	0.000202	0.000644	CcSEcCtD
Melphalan—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000201	0.000643	CcSEcCtD
Melphalan—Pain—Losartan—type 2 diabetes mellitus	0.000201	0.000643	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000199	0.00274	CbGpPWpGaD
Melphalan—Rash—Gliclazide—type 2 diabetes mellitus	0.000199	0.000638	CcSEcCtD
Melphalan—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000199	0.000637	CcSEcCtD
Melphalan—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000199	0.000636	CcSEcCtD
Melphalan—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000198	0.000634	CcSEcCtD
Melphalan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000197	0.000631	CcSEcCtD
Melphalan—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000197	0.000629	CcSEcCtD
Melphalan—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000197	0.000628	CcSEcCtD
Melphalan—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000196	0.000626	CcSEcCtD
Melphalan—Anorexia—Ramipril—type 2 diabetes mellitus	0.000192	0.000614	CcSEcCtD
Melphalan—Asthenia—Metformin—type 2 diabetes mellitus	0.00019	0.000607	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000189	0.00259	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CD36—type 2 diabetes mellitus	0.000188	0.00259	CbGpPWpGaD
Melphalan—Hypotension—Ramipril—type 2 diabetes mellitus	0.000188	0.000602	CcSEcCtD
Melphalan—Nausea—Gliclazide—type 2 diabetes mellitus	0.000188	0.000601	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000188	0.00258	CbGpPWpGaD
Melphalan—Pruritus—Metformin—type 2 diabetes mellitus	0.000187	0.000599	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000187	0.00257	CbGpPWpGaD
Melphalan—Urticaria—Losartan—type 2 diabetes mellitus	0.000187	0.000597	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000186	0.00256	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BHMT—type 2 diabetes mellitus	0.000186	0.00256	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PPP2CA—type 2 diabetes mellitus	0.000186	0.00256	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000186	0.00256	CbGpPWpGaD
Melphalan—Vomiting—Valsartan—type 2 diabetes mellitus	0.000185	0.000591	CcSEcCtD
Melphalan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000184	0.000588	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000184	0.000587	CcSEcCtD
Melphalan—Rash—Valsartan—type 2 diabetes mellitus	0.000183	0.000586	CcSEcCtD
Melphalan—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000183	0.000585	CcSEcCtD
Melphalan—Vomiting—Orlistat—type 2 diabetes mellitus	0.000183	0.000584	CcSEcCtD
Melphalan—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000181	0.000579	CcSEcCtD
Melphalan—Rash—Orlistat—type 2 diabetes mellitus	0.000181	0.000579	CcSEcCtD
Melphalan—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000181	0.000579	CcSEcCtD
Melphalan—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000181	0.000578	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.00018	0.00248	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.00018	0.00247	CbGpPWpGaD
Melphalan—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00018	0.000574	CcSEcCtD
Melphalan—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000179	0.000573	CcSEcCtD
Melphalan—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000177	0.000567	CcSEcCtD
Melphalan—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000177	0.000565	CcSEcCtD
Melphalan—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000175	0.00056	CcSEcCtD
Melphalan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000174	0.000556	CcSEcCtD
Melphalan—Fatigue—Ramipril—type 2 diabetes mellitus	0.000174	0.000556	CcSEcCtD
Melphalan—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000173	0.000554	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000173	0.00238	CbGpPWpGaD
Melphalan—Nausea—Valsartan—type 2 diabetes mellitus	0.000173	0.000552	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—MMP1—type 2 diabetes mellitus	0.000172	0.00236	CbGpPWpGaD
Melphalan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000171	0.000546	CcSEcCtD
Melphalan—Nausea—Orlistat—type 2 diabetes mellitus	0.000171	0.000545	CcSEcCtD
Melphalan—Asthenia—Losartan—type 2 diabetes mellitus	0.000169	0.000539	CcSEcCtD
Melphalan—Vomiting—Metformin—type 2 diabetes mellitus	0.000168	0.000538	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000168	0.00231	CbGpPWpGaD
Melphalan—Rash—Metformin—type 2 diabetes mellitus	0.000167	0.000534	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—CALM1—type 2 diabetes mellitus	0.000167	0.00229	CbGpPWpGaD
Melphalan—Dermatitis—Metformin—type 2 diabetes mellitus	0.000167	0.000533	CcSEcCtD
Melphalan—Pruritus—Losartan—type 2 diabetes mellitus	0.000166	0.000532	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—APOA1—type 2 diabetes mellitus	0.000164	0.00226	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGDS—type 2 diabetes mellitus	0.000163	0.00224	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AANAT—type 2 diabetes mellitus	0.000163	0.00224	CbGpPWpGaD
Melphalan—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000161	0.000514	CcSEcCtD
Melphalan—Urticaria—Ramipril—type 2 diabetes mellitus	0.00016	0.000512	CcSEcCtD
Melphalan—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000159	0.000508	CcSEcCtD
Melphalan—Rash—Irbesartan—type 2 diabetes mellitus	0.000157	0.000503	CcSEcCtD
Melphalan—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000157	0.000503	CcSEcCtD
Melphalan—Nausea—Metformin—type 2 diabetes mellitus	0.000157	0.000503	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PRKCB—type 2 diabetes mellitus	0.000157	0.00216	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS2—type 2 diabetes mellitus	0.000155	0.00213	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPD2—type 2 diabetes mellitus	0.000154	0.00212	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CDO1—type 2 diabetes mellitus	0.000154	0.00212	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000152	0.00209	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.00015	0.00206	CbGpPWpGaD
Melphalan—Vomiting—Losartan—type 2 diabetes mellitus	0.000149	0.000478	CcSEcCtD
Melphalan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000149	0.000475	CcSEcCtD
Melphalan—Nausea—Irbesartan—type 2 diabetes mellitus	0.000148	0.000474	CcSEcCtD
Melphalan—Rash—Losartan—type 2 diabetes mellitus	0.000148	0.000474	CcSEcCtD
Melphalan—Dermatitis—Losartan—type 2 diabetes mellitus	0.000148	0.000473	CcSEcCtD
Melphalan—SLC22A3—Metabolism—AK1—type 2 diabetes mellitus	0.000147	0.00202	CbGpPWpGaD
Melphalan—Asthenia—Ramipril—type 2 diabetes mellitus	0.000145	0.000462	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000143	0.00197	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000143	0.00197	CbGpPWpGaD
Melphalan—Pruritus—Ramipril—type 2 diabetes mellitus	0.000143	0.000456	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000142	0.00196	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00014	0.00192	CbGpPWpGaD
Melphalan—Nausea—Losartan—type 2 diabetes mellitus	0.00014	0.000446	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000139	0.00191	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000138	0.0019	CbGpPWpGaD
Melphalan—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000138	0.000441	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IGF1—type 2 diabetes mellitus	0.000137	0.00189	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT2—type 2 diabetes mellitus	0.000137	0.00189	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000136	0.00187	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MAT1A—type 2 diabetes mellitus	0.000136	0.00187	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000131	0.0018	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HBA2—type 2 diabetes mellitus	0.000131	0.0018	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ENPP1—type 2 diabetes mellitus	0.000131	0.0018	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ND1—type 2 diabetes mellitus	0.000131	0.0018	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—G6PC—type 2 diabetes mellitus	0.000131	0.0018	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SERPINE1—type 2 diabetes mellitus	0.00013	0.00179	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALB—type 2 diabetes mellitus	0.00013	0.00179	CbGpPWpGaD
Melphalan—Vomiting—Ramipril—type 2 diabetes mellitus	0.000128	0.00041	CcSEcCtD
Melphalan—Rash—Ramipril—type 2 diabetes mellitus	0.000127	0.000406	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GCGR—type 2 diabetes mellitus	0.000127	0.00175	CbGpPWpGaD
Melphalan—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000127	0.000406	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PIK3R1—type 2 diabetes mellitus	0.000125	0.00171	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS3—type 2 diabetes mellitus	0.000125	0.00171	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000122	0.00168	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYTB—type 2 diabetes mellitus	0.00012	0.00165	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—OXCT1—type 2 diabetes mellitus	0.00012	0.00165	CbGpPWpGaD
Melphalan—Nausea—Ramipril—type 2 diabetes mellitus	0.00012	0.000383	CcSEcCtD
Melphalan—SLC22A3—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000117	0.00161	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000116	0.0016	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000113	0.00155	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000113	0.00155	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ACACA—type 2 diabetes mellitus	0.000111	0.00153	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000111	0.00153	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—STAR—type 2 diabetes mellitus	0.000111	0.00153	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000111	0.00153	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CBS—type 2 diabetes mellitus	0.000107	0.00147	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCC8—type 2 diabetes mellitus	0.000107	0.00147	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—COX2—type 2 diabetes mellitus	0.000103	0.00142	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000103	0.00142	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NCOA6—type 2 diabetes mellitus	0.000101	0.00139	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—UCP3—type 2 diabetes mellitus	9.94e-05	0.00137	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—UCP2—type 2 diabetes mellitus	9.94e-05	0.00137	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HSD11B1—type 2 diabetes mellitus	9.94e-05	0.00137	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.61e-05	0.00132	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.56e-05	0.00132	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.48e-05	0.0013	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PCK1—type 2 diabetes mellitus	9.34e-05	0.00128	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SRC—type 2 diabetes mellitus	9.21e-05	0.00127	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.16e-05	0.00126	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFA—type 2 diabetes mellitus	8.97e-05	0.00123	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HK1—type 2 diabetes mellitus	8.75e-05	0.0012	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.56e-05	0.00118	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LPA—type 2 diabetes mellitus	8.45e-05	0.00116	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HSD3B2—type 2 diabetes mellitus	8.45e-05	0.00116	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—KCNJ11—type 2 diabetes mellitus	8.45e-05	0.00116	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GCKR—type 2 diabetes mellitus	8.45e-05	0.00116	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TGFB1—type 2 diabetes mellitus	8.24e-05	0.00113	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALDOB—type 2 diabetes mellitus	8.1e-05	0.00111	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.73e-05	0.00106	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GLP1R—type 2 diabetes mellitus	7.53e-05	0.00104	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.25e-05	0.000997	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC2A2—type 2 diabetes mellitus	7.03e-05	0.000967	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CPT1A—type 2 diabetes mellitus	6.89e-05	0.000947	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTR—type 2 diabetes mellitus	6.89e-05	0.000947	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NAMPT—type 2 diabetes mellitus	6.75e-05	0.000929	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LIPC—type 2 diabetes mellitus	6.71e-05	0.000923	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HBA1—type 2 diabetes mellitus	6.71e-05	0.000923	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GCK—type 2 diabetes mellitus	6.71e-05	0.000923	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP11A1—type 2 diabetes mellitus	6.67e-05	0.000917	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC9A1—type 2 diabetes mellitus	6.55e-05	0.000901	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CETP—type 2 diabetes mellitus	6.48e-05	0.000891	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PSMD6—type 2 diabetes mellitus	6.02e-05	0.000828	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SREBF1—type 2 diabetes mellitus	6.02e-05	0.000828	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SNAP25—type 2 diabetes mellitus	6.02e-05	0.000828	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CTGF—type 2 diabetes mellitus	5.91e-05	0.000813	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HMGCR—type 2 diabetes mellitus	5.86e-05	0.000805	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.74e-05	0.00079	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ADRA2A—type 2 diabetes mellitus	5.73e-05	0.000788	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT1—type 2 diabetes mellitus	5.73e-05	0.000787	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2E1—type 2 diabetes mellitus	5.51e-05	0.000757	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC2A1—type 2 diabetes mellitus	5.44e-05	0.000749	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP1A2—type 2 diabetes mellitus	5.44e-05	0.000749	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP3A4—type 2 diabetes mellitus	5.31e-05	0.00073	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GCG—type 2 diabetes mellitus	5.22e-05	0.000718	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC2A4—type 2 diabetes mellitus	5.22e-05	0.000718	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GNB3—type 2 diabetes mellitus	4.5e-05	0.000619	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.5e-05	0.000619	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HMOX1—type 2 diabetes mellitus	4.48e-05	0.000616	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAT—type 2 diabetes mellitus	4.42e-05	0.000608	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOB—type 2 diabetes mellitus	4.29e-05	0.00059	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTM1—type 2 diabetes mellitus	4.17e-05	0.000574	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LPL—type 2 diabetes mellitus	4.1e-05	0.000563	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ADCY5—type 2 diabetes mellitus	4.01e-05	0.000552	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPX1—type 2 diabetes mellitus	4e-05	0.00055	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CD36—type 2 diabetes mellitus	3.89e-05	0.000535	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPP2CA—type 2 diabetes mellitus	3.84e-05	0.000529	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTHFR—type 2 diabetes mellitus	3.69e-05	0.000507	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARA—type 2 diabetes mellitus	3.62e-05	0.000498	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AGT—type 2 diabetes mellitus	3.5e-05	0.000482	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CALM1—type 2 diabetes mellitus	3.45e-05	0.000474	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOE—type 2 diabetes mellitus	3.43e-05	0.000472	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOA1—type 2 diabetes mellitus	3.39e-05	0.000467	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARG—type 2 diabetes mellitus	2.99e-05	0.000411	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—INS—type 2 diabetes mellitus	2.93e-05	0.000403	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—type 2 diabetes mellitus	2.69e-05	0.00037	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.57e-05	0.000354	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NOS3—type 2 diabetes mellitus	2.57e-05	0.000354	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—type 2 diabetes mellitus	2.35e-05	0.000324	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-05	0.000163	CbGpPWpGaD
